Novotech, an Australian CRO, Opens Shanghai Office

Novotech, a pan-Asia clinical-stage CRO headquartered in Australia, has opened a Shanghai office, a wholly owned entity with a local staff. Previously, Novotech operated in China through partners. The company was responding, it said, to the requests of its international pharma clients for China trials. Novotech pointed out that China is the largest site for clinical trials in Asia and the fifth largest in the world. More details.... Share this with colleagues: // //